Advanced visualization software developer Imaging Biometrics is directing attention to a study presented at the recent International Society for Magnetic Resonance in Medicine (ISMRM) meeting in Toronto involving its IB Neuro dynamic susceptibility contrast (DSC) software.
In the study, researchers from the Medical College of Wisconsin determined the threshold value of relative cerebral blood volume (rCBV) that would distinguish tissue comprised of glioblastoma from tissue altered by treatment, according to the company. They found that rCBV could be used to distinguish between glioblastoma and radiation effect, whereas diffusion parameters such as apparent diffusion coefficient could not, Imaging Biometrics said.
